Trophic macrophages in development and disease.

PubWeight™: 5.37‹?› | Rank: Top 1%

🔗 View Article (PMC 3648866)

Published in Nat Rev Immunol on April 01, 2009

Authors

Jeffrey W Pollard1

Author Affiliations

1: Department of Developmental and Molecular Biology, Center for the Study of Reproductive Biology and Women's Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Chanin 607, Bronx, New York 10461, USA. pollard@aecom.yu.edu

Articles citing this

(truncated to the top 100)

Macrophage diversity enhances tumor progression and metastasis. Cell (2010) 13.41

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol (2010) 9.59

Macrophage biology in development, homeostasis and disease. Nature (2013) 8.28

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov (2011) 7.65

Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med (2011) 4.91

Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest (2010) 4.56

Tissue-resident macrophages. Nat Immunol (2013) 4.09

Tumors as organs: complex tissues that interface with the entire organism. Dev Cell (2010) 3.98

A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One (2009) 3.86

Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature (2014) 3.31

Differential macrophage programming in the tumor microenvironment. Trends Immunol (2012) 3.18

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One (2010) 3.14

Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol (2009) 3.07

Targeting the tumour vasculature: insights from physiological angiogenesis. Nat Rev Cancer (2010) 2.93

Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol (2010) 2.66

TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol (2010) 2.61

Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell Metab (2013) 2.23

Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection. Nat Immunol (2013) 2.22

Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology (2013) 2.21

Immune cell promotion of metastasis. Nat Rev Immunol (2015) 2.15

M1 and M2 macrophages: the chicken and the egg of immunity. J Innate Immun (2014) 2.06

CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages. J Exp Med (2015) 2.05

Transcript origin analysis identifies antigen-presenting cells as primary targets of socially regulated gene expression in leukocytes. Proc Natl Acad Sci U S A (2011) 2.03

From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation. Front Immunol (2014) 2.03

Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells. Cancer Cell (2014) 2.00

CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res (2014) 2.00

CSF-1 signaling mediates recovery from acute kidney injury. J Clin Invest (2012) 1.98

Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells. Cancer Cell (2012) 1.95

Macrophages and therapeutic resistance in cancer. Cancer Cell (2015) 1.95

Studying the mononuclear phagocyte system in the molecular age. Nat Rev Immunol (2011) 1.93

Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits. PLoS One (2011) 1.92

Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. J Clin Invest (2013) 1.92

Role of ABL family kinases in cancer: from leukaemia to solid tumours. Nat Rev Cancer (2013) 1.92

Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment. Clin Exp Immunol (2012) 1.90

Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia. Nat Med (2013) 1.89

Leukocytes in mammary development and cancer. Cold Spring Harb Perspect Biol (2011) 1.88

Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials (2012) 1.81

KIM-1-mediated phagocytosis reduces acute injury to the kidney. J Clin Invest (2015) 1.80

GATA3 in development and cancer differentiation: cells GATA have it! J Cell Physiol (2010) 1.80

TGF-β signaling in myeloid cells is required for tumor metastasis. Cancer Discov (2013) 1.76

Lymphocytes in cancer development: polarization towards pro-tumor immunity. Cytokine Growth Factor Rev (2009) 1.68

Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling. Mol Med (2012) 1.64

Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J Immunol (2009) 1.64

CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8(+) T cells. Oncoimmunology (2013) 1.57

Macrophage heterogeneity in tissues: phenotypic diversity and functions. Immunol Rev (2014) 1.55

Adipocyte-derived endotrophin promotes malignant tumor progression. J Clin Invest (2012) 1.55

The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. Br J Cancer (2013) 1.52

Macrophage polarization in inflammatory diseases. Int J Biol Sci (2014) 1.51

Retracted Effects of eicosapentaenoic acid and docosahexaenoic acid on prostate cancer cell migration and invasion induced by tumor-associated macrophages. PLoS One (2014) 1.50

Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms. Mediators Inflamm (2015) 1.48

The reactive stroma microenvironment and prostate cancer progression. Endocr Relat Cancer (2012) 1.46

Stress, inflammation, and defense of homeostasis. Mol Cell (2014) 1.44

Macrophage and adipocyte IGF1 maintain adipose tissue homeostasis during metabolic stresses. Obesity (Silver Spring) (2015) 1.41

Redox control of inflammation in macrophages. Antioxid Redox Signal (2013) 1.39

Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions. Arterioscler Thromb Vasc Biol (2011) 1.39

Colony-stimulating factor-1 promotes kidney growth and repair via alteration of macrophage responses. Am J Pathol (2011) 1.37

Identification of an adipogenic niche for adipose tissue remodeling and restoration. Cell Metab (2013) 1.36

Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes. Proc Natl Acad Sci U S A (2010) 1.35

M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7. Proc Natl Acad Sci U S A (2014) 1.35

Metchnikoff's policemen: macrophages in development, homeostasis and regeneration. Trends Mol Med (2011) 1.34

The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer. J Transl Med (2010) 1.33

ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages. Cell Res (2013) 1.32

The perivascular niche microenvironment in brain tumor progression. Cell Cycle (2010) 1.30

Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages. Cell (2014) 1.30

Tumor microenvironment: a main actor in the metastasis process. Clin Exp Metastasis (2012) 1.25

Twist1 induces CCL2 and recruits macrophages to promote angiogenesis. Cancer Res (2013) 1.24

New concepts on the immune modulation mediated by mesenchymal stem cells. Stem Cell Res Ther (2010) 1.24

Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. J Clin Invest (2014) 1.24

Three-dimensional migration of macrophages requires Hck for podosome organization and extracellular matrix proteolysis. Blood (2009) 1.18

Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. Nat Commun (2012) 1.18

Role of reactive oxygen and nitrogen species in the vascular responses to inflammation. Free Radic Biol Med (2011) 1.17

Intestinal macrophages: differentiation and involvement in intestinal immunopathologies. Semin Immunopathol (2009) 1.17

Serum response factor utilizes distinct promoter- and enhancer-based mechanisms to regulate cytoskeletal gene expression in macrophages. Mol Cell Biol (2010) 1.15

Functional diversity of microglia - how heterogeneous are they to begin with? Front Cell Neurosci (2013) 1.14

Novel Markers to Delineate Murine M1 and M2 Macrophages. PLoS One (2015) 1.13

Macrophages and angiogenesis: a role for Wnt signaling. Vasc Cell (2012) 1.12

Regulation of steady-state neutrophil homeostasis by macrophages. Blood (2010) 1.12

CD8+ tumor-infiltrating T cells are trapped in the tumor-dendritic cell network. Neoplasia (2013) 1.11

Tissue biology perspective on macrophages. Nat Immunol (2015) 1.11

CSF-1 receptor signaling in myeloid cells. Cold Spring Harb Perspect Biol (2014) 1.10

A membrane protease regulates energy production in macrophages by activating hypoxia-inducible factor-1 via a non-proteolytic mechanism. J Biol Chem (2010) 1.10

The role of B cells and humoral immunity in Mycobacterium tuberculosis infection. Adv Exp Med Biol (2013) 1.09

Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis. J Biol Chem (2014) 1.08

Density of tumor-associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma. Thyroid (2012) 1.08

Tumor-associated macrophages contribute to tumor progression in ovarian cancer. Front Oncol (2014) 1.08

The tumor microenvironment: a pitch for multiple players. Front Oncol (2013) 1.07

Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection. Gastric Cancer (2014) 1.07

Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression. Front Immunol (2014) 1.07

Macrophage-Induced Blood Vessels Guide Schwann Cell-Mediated Regeneration of Peripheral Nerves. Cell (2015) 1.07

Immune modulation of stem cells and regeneration. Cell Stem Cell (2014) 1.07

In vivo inhibition of c-MYC in myeloid cells impairs tumor-associated macrophage maturation and pro-tumoral activities. PLoS One (2012) 1.06

Differential macrophage polarization promotes tissue remodeling and repair in a model of ischemic retinopathy. Sci Rep (2011) 1.06

The role of macrophages in healing the wounded lung. Int J Exp Pathol (2012) 1.06

Monocytes and macrophages in cancer: development and functions. Cancer Microenviron (2012) 1.06

RAGE regulates the metabolic and inflammatory response to high-fat feeding in mice. Diabetes (2014) 1.05

TH2-Polarized CD4(+) T Cells and Macrophages Limit Efficacy of Radiotherapy. Cancer Immunol Res (2015) 1.03

Rethinking regenerative medicine: a macrophage-centered approach. Front Immunol (2014) 1.03

Vitamin D3 correlates inversely with systemic dendritic cell numbers and bone erosion in chronic rhinosinusitis with nasal polyps and allergic fungal rhinosinusitis. Clin Exp Immunol (2011) 1.03

Deciphering the roles of macrophages in developmental and inflammation stimulated lymphangiogenesis. Vasc Cell (2012) 1.01

Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor-associated macrophages (TAMs). J Biol Chem (2012) 1.00

Articles cited by this

(truncated to the top 100)

Inflammation and cancer. Nature (2002) 53.78

Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest (2003) 32.01

Alternative activation of macrophages. Nat Rev Immunol (2003) 27.53

Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell (1996) 23.99

Immunobiology of dendritic cells. Annu Rev Immunol (2000) 23.65

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol (2002) 17.85

Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell (2006) 13.79

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med (2004) 11.71

Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med (2001) 9.99

Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol (2006) 9.82

Role of angiogenesis in tumor growth and metastasis. Semin Oncol (2002) 9.77

VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell (2006) 9.32

Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell (2005) 9.06

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol (2002) 8.27

A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res (2004) 7.56

The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer (2008) 7.40

Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res (2007) 6.60

Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res (2006) 6.52

Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol (2008) 5.86

RANK is essential for osteoclast and lymph node development. Genes Dev (1999) 5.85

The origin and function of tumor-associated macrophages. Immunol Today (1992) 5.12

Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab (2008) 5.10

Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A (1990) 5.05

Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science (1994) 4.81

Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood (2002) 4.59

Macrophage diversity in renal injury and repair. J Clin Invest (2008) 4.41

"Re-educating" tumor-associated macrophages by targeting NF-kappaB. J Exp Med (2008) 4.38

The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull World Health Organ (1972) 4.25

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci U S A (1994) 4.19

Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol (2008) 4.17

A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood (2002) 4.06

Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev (2006) 4.02

Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci (2007) 3.93

Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development (1994) 3.86

A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood (2005) 3.85

Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science (2008) 3.83

Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature (2008) 3.82

Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol (2005) 3.67

Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res (2007) 3.49

WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature (2005) 3.44

Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience (1985) 3.27

Postnatal mammary gland development requires macrophages and eosinophils. Development (2000) 3.10

Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia (2002) 2.90

Macrophages as APC and the dendritic cell myth. J Immunol (2008) 2.90

Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol (2005) 2.81

The mononuclear phagocyte system. Curr Opin Immunol (2005) 2.65

Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci U S A (2006) 2.60

Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst (1994) 2.58

The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia (2002) 2.37

Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland. Dev Dyn (2006) 2.35

Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature (1997) 2.31

Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med (1998) 2.31

Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol (2003) 2.19

Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature (2008) 2.18

Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver. Science (2001) 2.17

Myeloid lineage progenitors give rise to vascular endothelium. Proc Natl Acad Sci U S A (2006) 2.13

Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Cancer Res (2004) 2.12

Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. EMBO J (2008) 2.05

Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development. Breast Cancer Res (2002) 1.90

Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages. Mol Oncol (2007) 1.88

Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. Am J Physiol Endocrinol Metab (2008) 1.84

Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol (2007) 1.84

Uterine DCs are crucial for decidua formation during embryo implantation in mice. J Clin Invest (2008) 1.82

A potential role of macrophage activation in the treatment of cancer. Crit Rev Oncol Hematol (2002) 1.81

High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors. Am J Pathol (2009) 1.80

Three pathways to mature macrophages in the early mouse yolk sac. Blood (2005) 1.76

Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. J Invest Dermatol (2007) 1.75

CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain. J Comp Neurol (2008) 1.72

Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts. Cancer Res (2006) 1.67

The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J Leukoc Biol (2000) 1.66

Mouse neutrophilic granulocytes express mRNA encoding the macrophage colony-stimulating factor receptor (CSF-1R) as well as many other macrophage-specific transcripts and can transdifferentiate into macrophages in vitro in response to CSF-1. J Leukoc Biol (2007) 1.63

Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor. Exp Hematol (1991) 1.62

Delayed hematopoietic development in osteopetrotic (op/op) mice. J Exp Med (1993) 1.62

Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r-EGFP transgene reporter. Dev Biol (2007) 1.61

Macrophages and dendritic cells constitute a major subpopulation of cells in the mouse dermis. J Invest Dermatol (2004) 1.60

Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB. Blood (2009) 1.59

Expression of Gal4-dependent transgenes in cells of the mononuclear phagocyte system labeled with enhanced cyan fluorescent protein using Csf1r-Gal4VP16/UAS-ECFP double-transgenic mice. J Leukoc Biol (2007) 1.57

Metchnikoff and the phagocytosis theory. Nat Rev Mol Cell Biol (2003) 1.56

Colony stimulating factor 1 is required for mammary gland development during pregnancy. Proc Natl Acad Sci U S A (1994) 1.53

Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth. J Clin Invest (1998) 1.51

Origins and tissue-context-dependent fates of blood monocytes. Immunol Cell Biol (2008) 1.50

The M cell as a portal of entry to the lung for the bacterial pathogen Mycobacterium tuberculosis. Immunity (1999) 1.50

Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice. J Leukoc Biol (2006) 1.48

Obligatory participation of macrophages in an angiopoietin 2-mediated cell death switch. Development (2007) 1.47

Colony stimulating factor-1 is required to recruit macrophages into the mammary gland to facilitate mammary ductal outgrowth. Dev Biol (2002) 1.45

Differentiation of the mononuclear phagocyte system during mouse embryogenesis: the role of transcription factor PU.1. Blood (1999) 1.41

Macrophages kill capillary cells in G1 phase of the cell cycle during programmed vascular regression. Development (1999) 1.40

Microglia: phagocyte and glia cell. Int J Biochem Cell Biol (2005) 1.40

CSF-1 deficiency in the op/op mouse has differential effects on macrophage populations and differentiation stages. Exp Hematol (1992) 1.37

Macrophage contributions to ovarian function. Hum Reprod Update (2004) 1.35

The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: Evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification. Proc Natl Acad Sci U S A (2002) 1.34

Human macrophages rescue myoblasts and myotubes from apoptosis through a set of adhesion molecular systems. J Cell Sci (2006) 1.34

Myeloid development is selectively disrupted in PU.1 null mice. Blood (1998) 1.33

Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis. Cancer Sci (2007) 1.28

Absence of colony stimulating factor-1 in osteopetrotic (csfmop/csfmop) mice disrupts estrous cycles and ovulation. Biol Reprod (1997) 1.24

Insulin cell mass is altered in Csf1op/Csf1op macrophage-deficient mice. J Leukoc Biol (2004) 1.22

Absence of colony-stimulating factor-1 in osteopetrotic (csfmop/csfmop) mice results in male fertility defects. Biol Reprod (1996) 1.20

Qualitative and quantitative aspects of haematopoietic cell development in the mammalian embryo. Immunol Today (1998) 1.18